Rheumatoid Diseases
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinnova-RD: A Prospective Cohort Study of Patients With Rheumatoid Diseases (NCT06235684) | Luxembourg Institute of Health | 2026-04-01 |
| Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (NCT02605642) | Pfizer | 2015-09-10 |
Track Rheumatoid Diseases automatically
Every clearance here is in the API, with alerts when new ones post.